Changchun BCHT Biotechnology Co. (SHA:688276)

SHA:688276 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,607	1,825	1,071	1,201	1,440	974.39
Other Revenue	0.14	0.14	0.05	0.75	1.36	1.27
Revenue	1,608	1,825	1,071	1,202	1,441	975.67
Revenue Growth (YoY)	10.95%	70.30%	-10.86%	-16.61%	47.73%	-4.25%
Cost of Revenue	220.26	210.35	181.93	228.56	176.27	102.74
Gross Profit	1,387	1,614	889.52	973.47	1,265	872.93
Selling, General & Admin	703.86	800.93	552.73	555.93	689.48	523.61
Research & Development	177.89	198.07	133.53	156.76	93.36	65.16
Other Operating Expenses	14.41	13.04	9.7	10.58	10.67	7.93
Operating Expenses	937.15	1,072	729.59	734.04	792.91	591.1
Operating Income	450.09	541.96	159.93	239.43	472.18	281.83
Interest Expense	-1.46	-0.7	-	-0.33	-4.05	-8.3
Interest & Investment Income	6.12	12.44	18.4	11.78	7.34	0.49
Earnings From Equity Investments	0.05	0.69	0.31	-1.02	-	-
Currency Exchange Gain (Loss)	0.67	0.67	1.86	-0.14	-0.22	0.12
Other Non Operating Income (Expenses)	-4.21	-0.21	-0.15	-0.16	-0.16	-0.1
EBT Excluding Unusual Items	451.27	554.85	180.35	249.55	475.09	274.04
Gain (Loss) on Sale of Investments	-	-	-	-	-	-13.9
Gain (Loss) on Sale of Assets	-0.9	-0.9	-0.73	-2.19	-	15.34
Asset Writedown	10.03	-	-	-	-0.05	-9.82
Other Unusual Items	2.32	2.91	18.07	14.2	11.61	-1.82
Pretax Income	469.62	563.76	197.69	261.57	486.65	263.84
Income Tax Expense	55.33	62.75	16.16	18.01	68.42	42.81
Net Income	414.29	501.01	181.54	243.55	418.23	221.02
Net Income to Common	414.29	501.01	181.54	243.55	418.23	221.02
Net Income Growth	37.72%	175.98%	-25.46%	-41.77%	89.23%	72.60%
Shares Outstanding (Basic)	414	414	413	393	367	362
Shares Outstanding (Diluted)	414	414	413	393	367	362
Shares Change (YoY)	0.68%	0.36%	5.03%	7.07%	1.25%	1.86%
EPS (Basic)	1.00	1.21	0.44	0.62	1.14	0.61
EPS (Diluted)	1.00	1.21	0.44	0.62	1.14	0.61
EPS Growth	36.79%	175.00%	-29.03%	-45.61%	86.89%	69.44%
Free Cash Flow	-175.73	-215.46	-250.91	-492.58	-126.58	104.4
Free Cash Flow Per Share	-0.42	-0.52	-0.61	-1.25	-0.34	0.29
Dividend Per Share	0.150	0.150	0.150	0.100	-	-
Dividend Growth	-	-	50.00%	-	-	-
Gross Margin	86.30%	88.47%	83.02%	80.98%	87.77%	89.47%
Operating Margin	28.00%	29.70%	14.93%	19.92%	32.76%	28.89%
Profit Margin	25.77%	27.46%	16.94%	20.26%	29.02%	22.65%
Free Cash Flow Margin	-10.93%	-11.81%	-23.42%	-40.98%	-8.78%	10.70%
EBITDA	557.86	633.94	230.87	307.76	531.04	324.59
EBITDA Margin	34.70%	34.74%	21.55%	25.60%	36.84%	33.27%
D&A For EBITDA	107.77	91.99	70.94	68.34	58.86	42.76
EBIT	450.09	541.96	159.93	239.43	472.18	281.83
EBIT Margin	28.00%	29.70%	14.93%	19.92%	32.76%	28.89%
Effective Tax Rate	11.78%	11.13%	8.17%	6.89%	14.06%	16.23%
Revenue as Reported	1,608	1,825	1,071	1,202	1,441	-
Advertising Expenses	-	568.76	371.28	411.83	540.22	386.13

Source: S&P Global Market Intelligence. Standard template. Financial Sources.